Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.2.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Collaboration revenue $ 349,943 $ 483,626
Operating expenses:    
Research and development 21,444,019 16,634,553
General and administrative 8,575,283 8,936,509
Total operating expenses 30,019,302 25,571,062
Loss from operations (29,669,359) (25,087,436)
Interest income 15
Foreign exchange loss (52,482) (22,041)
Other income 125,501
Net loss $ (29,721,841) $ (24,983,961)
Per share information:    
Net loss per share, basic and diluted $ (6.84) $ (14.25)
Weighted average shares outstanding, basic and diluted 4,348,166 1,753,378